This inventor holds 1 USPTO granted patent. Top assignee: 3Sm Biotron Inc.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: The Innovations of Jiunn-Yuan Hsu
Introduction: Jiunn-Yuan Hsu is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of inhibitors for Fms-like tyrosine kinase (FLT3). His work is crucial in the ongoing fight against tumors, showcasing the importance of innovation in medical research.
Latest Patents: Jiunn-Yuan Hsu holds a patent for "Fms-like tyrosine kinase inhibitors." This invention relates to novel 4-quinolinone derivatives that serve as FLT3 inhibitors. These compounds are designed for the treatment and prevention of tumors, highlighting Hsu's commitment to advancing cancer therapies. He has 1 patent to his name.
Career Highlights: Hsu is currently associated with 3SM Biotron Inc., where he continues to push the boundaries of research in biotechnology. His work at the company emphasizes the application of innovative solutions to complex medical challenges.
Collaborations: Throughout his career, Jiunn-Yuan Hsu has collaborated with notable colleagues, including Jung-Hsiang Chen and Tsung-Chih Chen. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.
Conclusion: Jiunn-Yuan Hsu's contributions to the field of biotechnology, particularly through his patent on FLT3 inhibitors, demonstrate the vital role of inventors in advancing medical science. His ongoing work at 3SM Biotron Inc. and collaborations with esteemed colleagues further solidify his impact in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile